Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023

Author: Benzinga Insights | March 29, 2023 11:00am

Upgrades

According to Sidoti & Co., the prior rating for Federal Agricultural Mortgage Corp (NYSE:AGM) was changed from Neutral to Buy. In the fourth quarter, Federal Agricultural showed an EPS of $3.16, compared to $2.76 from the year-ago quarter. The current stock performance of Federal Agricultural shows a 52-week-high of $149.37 and a 52-week-low of $90.44. Moreover, at the end of the last trading period, the closing price was at $126.74.

According to Credit Suisse, the prior rating for Enbridge Inc (NYSE:ENB) was changed from Underperform to Neutral. Enbridge earned $0.47 in the fourth quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.67 and a 52-week-low of $35.04. Enbridge closed at $36.73 at the end of the last trading period.

B of A Securities upgraded the previous rating for NEXTracker Inc (NASDAQ:NXT) from Neutral to Buy. The current stock performance of NEXTracker shows a 52-week-high of $35.10 and a 52-week-low of $28.24. Moreover, at the end of the last trading period, the closing price was at $32.52.

Susquehanna upgraded the previous rating for Carnival Corp (NYSE:CCL) from Neutral to Positive. In the first quarter, Carnival showed an EPS of $0.55, compared to $1.66 from the year-ago quarter. The stock has a 52-week-high of $21.49 and a 52-week-low of $6.12. At the end of the last trading period, Carnival closed at $9.33.

According to Citigroup, the prior rating for Lululemon Athletica Inc (NASDAQ:LULU) was changed from Neutral to Buy. For the fourth quarter, Lululemon Athletica had an EPS of $4.40, compared to year-ago quarter EPS of $3.37. The current stock performance of Lululemon Athletica shows a 52-week-high of $410.70 and a 52-week-low of $252.01. Moreover, at the end of the last trading period, the closing price was at $320.31.

Credit Suisse upgraded the previous rating for Invesco Ltd (NYSE:IVZ) from Underperform to Neutral. For the fourth quarter, Invesco had an EPS of $0.39, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $23.83 and a 52-week-low of $13.20. Invesco closed at $15.62 at the end of the last trading period.

Goldman Sachs upgraded the previous rating for Marathon Petroleum Corp (NYSE:MPC) from Neutral to Buy. In the fourth quarter, Marathon Petroleum showed an EPS of $6.65, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $136.46 and a 52-week-low of $77.62. Marathon Petroleum closed at $131.57 at the end of the last trading period.

Goldman Sachs upgraded the previous rating for The Hartford Financial Services Group Inc (NYSE:HIG) from Neutral to Buy. For the fourth quarter, Hartford Finl Servs Gr had an EPS of $2.31, compared to year-ago quarter EPS of $2.02. At the moment, the stock has a 52-week-high of $79.44 and a 52-week-low of $60.19. Hartford Finl Servs Gr closed at $67.00 at the end of the last trading period.

For The Hershey Co (NYSE:HSY), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. Hershey earned $2.02 in the fourth quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $253.97 and a 52-week-low of $201.66. Hershey closed at $252.90 at the end of the last trading period.

Exane BNP Paribas upgraded the previous rating for Omnicom Group Inc (NYSE:OMC) from Underperform to Neutral. For the fourth quarter, Omnicom Group had an EPS of $2.09, compared to year-ago quarter EPS of $1.95. The stock has a 52-week-high of $96.52 and a 52-week-low of $61.38. At the end of the last trading period, Omnicom Group closed at $88.73.

UBS upgraded the previous rating for ArcelorMittal SA (NYSE:MT) from Sell to Buy. In the fourth quarter, ArcelorMittal showed an EPS of $0.30, compared to $3.70 from the year-ago quarter. The current stock performance of ArcelorMittal shows a 52-week-high of $33.90 and a 52-week-low of $19.25. Moreover, at the end of the last trading period, the closing price was at $28.90.

According to CFRA, the prior rating for Charter Communications Inc (NASDAQ:CHTR) was changed from Underweight to Market Weight. In the fourth quarter, Charter Communications showed an EPS of $7.69, compared to $8.93 from the year-ago quarter. The current stock performance of Charter Communications shows a 52-week-high of $574.65 and a 52-week-low of $297.83. Moreover, at the end of the last trading period, the closing price was at $345.54.

See all analyst ratings upgrades.

Downgrades

Gordon Haskett downgraded the previous rating for Macy's Inc (NYSE:M) from Accumulate to Hold. In the fourth quarter, Macy's showed an EPS of $1.88, compared to $2.45 from the year-ago quarter. The stock has a 52-week-high of $27.28 and a 52-week-low of $15.11. At the end of the last trading period, Macy's closed at $17.27.

For Vermilion Energy Inc (NYSE:VET), TD Cowen downgraded the previous rating of Buy to Hold. Vermilion Energy earned $1.80 in the fourth quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.16 and a 52-week-low of $11.93. Vermilion Energy closed at $12.75 at the end of the last trading period.

Maxim Group downgraded the previous rating for Generation Income Properties Inc (NASDAQ:GIPR) from Buy to Hold. The stock has a 52-week-high of $7.75 and a 52-week-low of $4.66. At the end of the last trading period, Generation Income closed at $4.90.

For Monopar Therapeutics Inc (NASDAQ:MNPR), Maxim Group downgraded the previous rating of Buy to Hold. For the fourth quarter, Monopar Therapeutics had an EPS of $0.22, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $4.88 and a 52-week-low of $1.35. At the end of the last trading period, Monopar Therapeutics closed at $1.45.

For Vermilion Energy Inc (NYSE:VET), TD Securities downgraded the previous rating of Buy to Hold. In the fourth quarter, Vermilion Energy showed an EPS of $1.80, compared to $1.68 from the year-ago quarter. The stock has a 52-week-high of $30.16 and a 52-week-low of $11.93. At the end of the last trading period, Vermilion Energy closed at $12.75.

According to UBS, the prior rating for Foot Locker Inc (NYSE:FL) was changed from Neutral to Sell. For the fourth quarter, Foot Locker had an EPS of $0.97, compared to year-ago quarter EPS of $1.67. The current stock performance of Foot Locker shows a 52-week-high of $47.22 and a 52-week-low of $23.86. Moreover, at the end of the last trading period, the closing price was at $40.03.

UBS downgraded the previous rating for Urban Outfitters Inc (NASDAQ:URBN) from Neutral to Sell. For the fourth quarter, Urban Outfitters had an EPS of $0.34, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $29.74 and a 52-week-low of $17.84. Urban Outfitters closed at $26.76 at the end of the last trading period.

For Burlington Stores Inc (NYSE:BURL), UBS downgraded the previous rating of Neutral to Sell. Burlington Stores earned $2.96 in the fourth quarter, compared to $2.53 in the year-ago quarter. The stock has a 52-week-high of $239.94 and a 52-week-low of $106.81. At the end of the last trading period, Burlington Stores closed at $201.27.

For Ross Stores Inc (NASDAQ:ROST), UBS downgraded the previous rating of Neutral to Sell. Ross Stores earned $1.31 in the fourth quarter, compared to $1.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $122.44 and a 52-week-low of $69.24. Ross Stores closed at $103.14 at the end of the last trading period.

For Bath & Body Works Inc (NYSE:BBWI), UBS downgraded the previous rating of Buy to Neutral. Bath & Body Works earned $1.86 in the fourth quarter, compared to $2.30 in the year-ago quarter. The current stock performance of Bath & Body Works shows a 52-week-high of $57.90 and a 52-week-low of $25.81. Moreover, at the end of the last trading period, the closing price was at $38.04.

According to Needham, the prior rating for Penumbra Inc (NYSE:PEN) was changed from Buy to Hold. Penumbra earned $0.16 in the fourth quarter, compared to $0.10 in the year-ago quarter. The current stock performance of Penumbra shows a 52-week-high of $283.42 and a 52-week-low of $115.08. Moreover, at the end of the last trading period, the closing price was at $275.54.

Exane BNP Paribas downgraded the previous rating for The Interpublic Group of Companies Inc (NYSE:IPG) from Outperform to Neutral. For the fourth quarter, Interpublic Gr of Cos had an EPS of $1.02, compared to year-ago quarter EPS of $0.82. At the moment, the stock has a 52-week-high of $39.52 and a 52-week-low of $25.14. Interpublic Gr of Cos closed at $35.24 at the end of the last trading period.

For Delek US Holdings Inc (NYSE:DK), Goldman Sachs downgraded the previous rating of Buy to Neutral. For the fourth quarter, Delek US Hldgs had an EPS of $0.88, compared to year-ago quarter EPS of $0.61. The current stock performance of Delek US Hldgs shows a 52-week-high of $35.23 and a 52-week-low of $19.27. Moreover, at the end of the last trading period, the closing price was at $23.49.

For Ciena Corp (NYSE:CIEN), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Ciena earned $0.64 in the first quarter, compared to $0.47 in the year-ago quarter. At the moment, the stock has a 52-week-high of $61.97 and a 52-week-low of $38.35. Ciena closed at $50.87 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

With a Buy rating, UBS initiated coverage on InMode Ltd (NASDAQ:INMD). The price target seems to have been set at $40.00 for InMode. For the fourth quarter, InMode had an EPS of $0.78, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $41.84 and a 52-week-low of $20.60. At the end of the last trading period, InMode closed at $30.00.

Craig-Hallum initiated coverage on Gambling.com Group Ltd (NASDAQ:GAMB) with a Buy rating. The price target for Gambling.com Gr is set to $15.00. For the fourth quarter, Gambling.com Gr had an EPS of $0.02, compared to year-ago quarter EPS of $0.02. The current stock performance of Gambling.com Gr shows a 52-week-high of $10.50 and a 52-week-low of $6.62. Moreover, at the end of the last trading period, the closing price was at $9.57.

EF Hutton initiated coverage on IN8bio Inc (NASDAQ:INAB) with a Buy rating. The price target for IN8bio is set to $8.00. IN8bio earned $0.34 in the third quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.88 and a 52-week-low of $1.12. IN8bio closed at $1.23 at the end of the last trading period.

Wells Fargo initiated coverage on AvalonBay Communities Inc (NYSE:AVB) with an Overweight rating. The price target for AvalonBay Communities is set to $184.00. AvalonBay Communities earned $2.59 in the fourth quarter, compared to $2.27 in the year-ago quarter. The stock has a 52-week-high of $258.92 and a 52-week-low of $153.07. At the end of the last trading period, AvalonBay Communities closed at $157.32.

With an Underweight rating, Wells Fargo initiated coverage on Camden Property Trust (NYSE:CPT). The price target seems to have been set at $102.00 for Camden Prop Trust. In the fourth quarter, Camden Prop Trust showed an EPS of $1.74, compared to $1.51 from the year-ago quarter. The stock has a 52-week-high of $175.69 and a 52-week-low of $97.74. At the end of the last trading period, Camden Prop Trust closed at $100.51.

With a Equal-Weight rating, Wells Fargo initiated coverage on Equity Residential (NYSE:EQR). The price target seems to have been set at $62.00 for Equity Residential. For the fourth quarter, Equity Residential had an EPS of $0.94, compared to year-ago quarter EPS of $0.82. At the moment, the stock has a 52-week-high of $94.31 and a 52-week-low of $54.60. Equity Residential closed at $55.92 at the end of the last trading period.

With an Underweight rating, Wells Fargo initiated coverage on Essex Property Trust Inc (NYSE:ESS). The price target seems to have been set at $208.00 for Essex Property Trust. For the fourth quarter, Essex Property Trust had an EPS of $3.77, compared to year-ago quarter EPS of $3.25. At the moment, the stock has a 52-week-high of $363.00 and a 52-week-low of $195.03. Essex Property Trust closed at $200.26 at the end of the last trading period.

Wells Fargo initiated coverage on UDR Inc (NYSE:UDR) with an Overweight rating. The price target for UDR is set to $44.50. In the fourth quarter, UDR showed an EPS of $0.61, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $60.01 and a 52-week-low of $37.18. At the end of the last trading period, UDR closed at $38.37.

With a Equal-Weight rating, Wells Fargo initiated coverage on American Homes 4 Rent (NYSE:AMH). The price target seems to have been set at $31.00 for American Homes 4 Rent. In the fourth quarter, American Homes 4 Rent showed an EPS of $0.40, compared to $0.37 from the year-ago quarter. The current stock performance of American Homes 4 Rent shows a 52-week-high of $43.88 and a 52-week-low of $28.79. Moreover, at the end of the last trading period, the closing price was at $29.80.

With an Overweight rating, Wells Fargo initiated coverage on Equity Lifestyle Properties Inc (NYSE:ELS). The price target seems to have been set at $75.50 for Equity Lifestyle Props. Equity Lifestyle Props earned $0.66 in the fourth quarter, compared to $0.64 in the year-ago quarter. The stock has a 52-week-high of $83.77 and a 52-week-low of $57.01. At the end of the last trading period, Equity Lifestyle Props closed at $63.91.

Wells Fargo initiated coverage on Sun Communities Inc (NYSE:SUI) with a Equal-Weight rating. The price target for Sun Communities is set to $151.00. In the fourth quarter, Sun Communities showed an EPS of $1.33, compared to $1.31 from the year-ago quarter. At the moment, the stock has a 52-week-high of $192.87 and a 52-week-low of $117.76. Sun Communities closed at $133.42 at the end of the last trading period.

HC Wainwright & Co. initiated coverage on Legend Biotech Corp (NASDAQ:LEGN) with a Buy rating. The price target for Legend Biotech is set to $66.00. Legend Biotech earned $0.24 in the first quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $57.72 and a 52-week-low of $33.05. At the end of the last trading period, Legend Biotech closed at $46.81.

Jefferies initiated coverage on Enliven Therapeutics Inc (NASDAQ:ELVN) with a Buy rating. The price target for Enliven Therapeutics is set to $27.00. At the moment, the stock has a 52-week-high of $25.34 and a 52-week-low of $19.24. Enliven Therapeutics closed at $23.49 at the end of the last trading period.

With a Neutral rating, Piper Sandler initiated coverage on SEI Investments Co (NASDAQ:SEIC). The price target seems to have been set at $60.00 for SEI Inv. For the fourth quarter, SEI Inv had an EPS of $0.83, compared to year-ago quarter EPS of $1.03. The stock has a 52-week-high of $64.69 and a 52-week-low of $46.30. At the end of the last trading period, SEI Inv closed at $55.83.

UBS initiated coverage on DexCom Inc (NASDAQ:DXCM) with a Buy rating. The price target for DexCom is set to $142.00. For the fourth quarter, DexCom had an EPS of $0.34, compared to year-ago quarter EPS of $0.17. At the moment, the stock has a 52-week-high of $134.50 and a 52-week-low of $66.94. DexCom closed at $113.81 at the end of the last trading period.

With a Buy rating, UBS initiated coverage on Inspire Medical Systems Inc (NYSE:INSP). The price target seems to have been set at $300.00 for Inspire Medical Systems. For the fourth quarter, Inspire Medical Systems had an EPS of $0.10, compared to year-ago quarter EPS of $0.09. The current stock performance of Inspire Medical Systems shows a 52-week-high of $282.31 and a 52-week-low of $142.75. Moreover, at the end of the last trading period, the closing price was at $238.62.

With a Buy rating, UBS initiated coverage on Boston Scientific Corp (NYSE:BSX). The price target seems to have been set at $57.00 for Boston Scientific. For the fourth quarter, Boston Scientific had an EPS of $0.45, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $49.22 and a 52-week-low of $34.98. Boston Scientific closed at $48.60 at the end of the last trading period.

UBS initiated coverage on Butterfly Network Inc (NYSE:BFLY) with a Neutral rating. The price target for Butterfly Network is set to $2.25. In the fourth quarter, Butterfly Network showed an EPS of $0.17, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.72 and a 52-week-low of $1.76. Butterfly Network closed at $1.77 at the end of the last trading period.

UBS initiated coverage on Baxter International Inc (NYSE:BAX) with a Neutral rating. The price target for Baxter Intl is set to $43.00. Baxter Intl earned $0.88 in the fourth quarter, compared to $1.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $80.71 and a 52-week-low of $37.34. Baxter Intl closed at $39.85 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Intuitive Surgical Inc (NASDAQ:ISRG). The price target seems to have been set at $278.00 for Intuitive Surgical. In the fourth quarter, Intuitive Surgical showed an EPS of $1.23, compared to $1.30 from the year-ago quarter. The current stock performance of Intuitive Surgical shows a 52-week-high of $308.21 and a 52-week-low of $180.34. Moreover, at the end of the last trading period, the closing price was at $249.49.

UBS initiated coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating. The price target for Johnson & Johnson is set to $164.00. Johnson & Johnson earned $2.35 in the fourth quarter, compared to $2.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $186.68 and a 52-week-low of $150.11. Johnson & Johnson closed at $151.82 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Tandem Diabetes Care Inc (NASDAQ:TNDM). The price target seems to have been set at $45.00 for Tandem Diabetes Care. For the fourth quarter, Tandem Diabetes Care had an EPS of $0.01, compared to year-ago quarter EPS of $0.16. At the moment, the stock has a 52-week-high of $123.96 and a 52-week-low of $33.52. Tandem Diabetes Care closed at $40.24 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Edwards Lifesciences Corp (NYSE:EW). The price target seems to have been set at $84.00 for Edwards Lifesciences. For the fourth quarter, Edwards Lifesciences had an EPS of $0.64, compared to year-ago quarter EPS of $0.51. The current stock performance of Edwards Lifesciences shows a 52-week-high of $131.09 and a 52-week-low of $67.13. Moreover, at the end of the last trading period, the closing price was at $80.49.

UBS initiated coverage on Stryker Corp (NYSE:SYK) with a Neutral rating. The price target for Stryker is set to $287.00. Stryker earned $3.00 in the fourth quarter, compared to $2.71 in the year-ago quarter. The stock has a 52-week-high of $284.00 and a 52-week-low of $188.92. At the end of the last trading period, Stryker closed at $277.41.

UBS initiated coverage on Zimmer Biomet Holdings Inc (NYSE:ZBH) with a Sell rating. The price target for Zimmer Biomet Holdings is set to $112.00. Zimmer Biomet Holdings earned $1.88 in the fourth quarter, compared to $1.95 in the year-ago quarter. At the moment, the stock has a 52-week-high of $135.00 and a 52-week-low of $100.41. Zimmer Biomet Holdings closed at $126.14 at the end of the last trading period.

Wells Fargo initiated coverage on Invitation Homes Inc (NYSE:INVH) with an Overweight rating. The price target for Invitation Homes is set to $33.50. For the fourth quarter, Invitation Homes had an EPS of $0.43, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $44.35 and a 52-week-low of $28.52. At the end of the last trading period, Invitation Homes closed at $29.46.

Mizuho initiated coverage on GitLab Inc (NASDAQ:GTLB) with a Neutral rating. The price target for GitLab is set to $38.00. In the fourth quarter, GitLab showed an EPS of $0.03, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $70.91 and a 52-week-low of $30.92. At the end of the last trading period, GitLab closed at $33.90.

With a Buy rating, Mizuho initiated coverage on Confluent Inc (NASDAQ:CFLT). The price target seems to have been set at $28.00 for Confluent. For the fourth quarter, Confluent had an EPS of $0.09, compared to year-ago quarter EPS of $0.19. The current stock performance of Confluent shows a 52-week-high of $44.95 and a 52-week-low of $16.50. Moreover, at the end of the last trading period, the closing price was at $20.97.

See all analyst ratings initiations.

Posted In: AGM AMH AVB BAX BBWI BFLY BSX BURL CCL CFLT CHTR CIEN CPT DK DXCM ELS ELVN ENB EQR ESS